Antiviral response and immunopathogenesis of interleukin 27 in COVID-19
ABSTRACT: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a high mortality rate. The clinical course is attributed to the severity of pneumonia and systemic complications. In COVID-19 patients and mu...
- Autores:
-
Valdés López, Juan Felipe
Urcuqui Inchima, Silvio
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2023
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/35521
- Acceso en línea:
- https://hdl.handle.net/10495/35521
- Palabra clave:
- SARS-CoV-2
COVID-19
Interleucina-27
Interleukin-27
Inmunidad Innata
Immunity, Innate
Receptores Toll-Like
Toll-Like Receptors
Inflamación
Inflammation
Interferones
Interferons
Antivirales - uso terapéutico
Antiviral Agents - therapeutic use
Progresión de la Enfermedad
Disease Progression
Citocinas
Cytokines
NF-kappa B
Ratones
Mice
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by/4.0/
